Development of a plant-produced recombinant monoclonal antibody against Δ-9-tetrahydrocannabinol (Δ9-THC) for immunoassay application

Δ-9-tetrahydrocannabinol (Δ9-THC) is mainly a psychoactive compound in the cannabis plant. The immunoassay, an alternative method to HPLC and GC, can be used to analyze and measure Δ9-THC. This method provides high sensitivity and specificity by using antibodies specific to the desired substances. C...

Full description

Bibliographic Details
Main Authors: Wanuttha Boonyayothin, Khwanlada Kobtrakul, Petlada Khositanon, Sornkanok Vimolmangkang, Waranyoo Phoolcharoen
Format: Article
Language:English
Published: Elsevier 2022-06-01
Series:Biotechnology Reports
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2215017X2200025X
_version_ 1811254140618145792
author Wanuttha Boonyayothin
Khwanlada Kobtrakul
Petlada Khositanon
Sornkanok Vimolmangkang
Waranyoo Phoolcharoen
author_facet Wanuttha Boonyayothin
Khwanlada Kobtrakul
Petlada Khositanon
Sornkanok Vimolmangkang
Waranyoo Phoolcharoen
author_sort Wanuttha Boonyayothin
collection DOAJ
description Δ-9-tetrahydrocannabinol (Δ9-THC) is mainly a psychoactive compound in the cannabis plant. The immunoassay, an alternative method to HPLC and GC, can be used to analyze and measure Δ9-THC. This method provides high sensitivity and specificity by using antibodies specific to the desired substances. Currently, plants provide several benefits over traditional expression platforms to produce recombinant antibodies, such as lower production costs and scalability. Therefore, this study aims to produce a recombinant anti-Δ9-THC monoclonal antibody (mAb) with transient expression using N. benthamiana. The highest expression level of the plant-produced mAb was estimated to be 0.33 ug/g leaf fresh weight. Our results demonstrate that the antibody provided in vitro affinity binding related to Δ9-THC and the metabolites of Δ9-THC, such as cannabinol (CBN). Moreover, the antibody also showed binding efficiency with Δ9-THC in cannabis extract. Moreover, plant-produced mAbs provide efficiency against Δ9-THC and can be applied for further immunoassay applications.
first_indexed 2024-04-12T17:01:48Z
format Article
id doaj.art-d1b669c87ed6461c838e18a1d5fef681
institution Directory Open Access Journal
issn 2215-017X
language English
last_indexed 2024-04-12T17:01:48Z
publishDate 2022-06-01
publisher Elsevier
record_format Article
series Biotechnology Reports
spelling doaj.art-d1b669c87ed6461c838e18a1d5fef6812022-12-22T03:24:03ZengElsevierBiotechnology Reports2215-017X2022-06-0134e00725Development of a plant-produced recombinant monoclonal antibody against Δ-9-tetrahydrocannabinol (Δ9-THC) for immunoassay applicationWanuttha Boonyayothin0Khwanlada Kobtrakul1Petlada Khositanon2Sornkanok Vimolmangkang3Waranyoo Phoolcharoen4Center of Excellence in Plant-Produced Pharmaceuticals, Chulalongkorn University, Bangkok, Thailand; Pharmaceutical Sciences and Technology Program, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok, Thailand; Department of Pharmacognosy and Pharmaceutical Botany, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok, ThailandPharmaceutical Sciences and Technology Program, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok, Thailand; Department of Pharmacognosy and Pharmaceutical Botany, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok, ThailandResearch Cluster for Cannabis and its Natural Substances, Chulalongkorn University, Bangkok, ThailandCenter of Excellence in Plant-Produced Pharmaceuticals, Chulalongkorn University, Bangkok, Thailand; Department of Pharmacognosy and Pharmaceutical Botany, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok, Thailand; Research Cluster for Cannabis and its Natural Substances, Chulalongkorn University, Bangkok, ThailandCenter of Excellence in Plant-Produced Pharmaceuticals, Chulalongkorn University, Bangkok, Thailand; Department of Pharmacognosy and Pharmaceutical Botany, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok, Thailand; Corresponding author at: Department of Pharmacognosy and Pharmaceutical Botany, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok, Thailand.Δ-9-tetrahydrocannabinol (Δ9-THC) is mainly a psychoactive compound in the cannabis plant. The immunoassay, an alternative method to HPLC and GC, can be used to analyze and measure Δ9-THC. This method provides high sensitivity and specificity by using antibodies specific to the desired substances. Currently, plants provide several benefits over traditional expression platforms to produce recombinant antibodies, such as lower production costs and scalability. Therefore, this study aims to produce a recombinant anti-Δ9-THC monoclonal antibody (mAb) with transient expression using N. benthamiana. The highest expression level of the plant-produced mAb was estimated to be 0.33 ug/g leaf fresh weight. Our results demonstrate that the antibody provided in vitro affinity binding related to Δ9-THC and the metabolites of Δ9-THC, such as cannabinol (CBN). Moreover, the antibody also showed binding efficiency with Δ9-THC in cannabis extract. Moreover, plant-produced mAbs provide efficiency against Δ9-THC and can be applied for further immunoassay applications.http://www.sciencedirect.com/science/article/pii/S2215017X2200025XPlant-produced mAbTransient expression(-)-Δ 9-tetrahydrocannabinol (Δ9-THC)Nicotiana benthamiana, Cannabis extractImmunoassay
spellingShingle Wanuttha Boonyayothin
Khwanlada Kobtrakul
Petlada Khositanon
Sornkanok Vimolmangkang
Waranyoo Phoolcharoen
Development of a plant-produced recombinant monoclonal antibody against Δ-9-tetrahydrocannabinol (Δ9-THC) for immunoassay application
Biotechnology Reports
Plant-produced mAb
Transient expression
(-)-Δ 9-tetrahydrocannabinol (Δ9-THC)
Nicotiana benthamiana, Cannabis extract
Immunoassay
title Development of a plant-produced recombinant monoclonal antibody against Δ-9-tetrahydrocannabinol (Δ9-THC) for immunoassay application
title_full Development of a plant-produced recombinant monoclonal antibody against Δ-9-tetrahydrocannabinol (Δ9-THC) for immunoassay application
title_fullStr Development of a plant-produced recombinant monoclonal antibody against Δ-9-tetrahydrocannabinol (Δ9-THC) for immunoassay application
title_full_unstemmed Development of a plant-produced recombinant monoclonal antibody against Δ-9-tetrahydrocannabinol (Δ9-THC) for immunoassay application
title_short Development of a plant-produced recombinant monoclonal antibody against Δ-9-tetrahydrocannabinol (Δ9-THC) for immunoassay application
title_sort development of a plant produced recombinant monoclonal antibody against δ 9 tetrahydrocannabinol δ9 thc for immunoassay application
topic Plant-produced mAb
Transient expression
(-)-Δ 9-tetrahydrocannabinol (Δ9-THC)
Nicotiana benthamiana, Cannabis extract
Immunoassay
url http://www.sciencedirect.com/science/article/pii/S2215017X2200025X
work_keys_str_mv AT wanutthaboonyayothin developmentofaplantproducedrecombinantmonoclonalantibodyagainstd9tetrahydrocannabinold9thcforimmunoassayapplication
AT khwanladakobtrakul developmentofaplantproducedrecombinantmonoclonalantibodyagainstd9tetrahydrocannabinold9thcforimmunoassayapplication
AT petladakhositanon developmentofaplantproducedrecombinantmonoclonalantibodyagainstd9tetrahydrocannabinold9thcforimmunoassayapplication
AT sornkanokvimolmangkang developmentofaplantproducedrecombinantmonoclonalantibodyagainstd9tetrahydrocannabinold9thcforimmunoassayapplication
AT waranyoophoolcharoen developmentofaplantproducedrecombinantmonoclonalantibodyagainstd9tetrahydrocannabinold9thcforimmunoassayapplication